Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Johnson and Johnson
Argus Health
Julphar
AstraZeneca
Deloitte
Boehringer Ingelheim
Dow

Generated: October 17, 2018

DrugPatentWatch Database Preview

TRIAMTERENE AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Triamterene And Hydrochlorothiazide, and what generic alternatives are available?

Triamterene And Hydrochlorothiazide is a drug marketed by Ani Pharms Inc, Casi Pharms Inc, Duramed Pharms Barr, Ivax Sub Teva Pharms, Lannett Co Inc, Mylan, Novartis, Sandoz, Vitarine, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, Watson Labs, and Zydus Pharms Usa Inc. and is included in twenty NDAs.

The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.

Summary for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Pharmacology for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Synonyms for TRIAMTERENE AND HYDROCHLOROTHIAZIDE
14124-50-6
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide, mixt. with 6-phenyl-2,4,7-pteridinetriamine
6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine- 7-sulfonamide, 1,1-dioxide, mixt. with 6-phenyl-2,4,7-pteridinetriamine
AC1L1Y34
C12H11N7.C7H8ClN3O4S2
DTXSID50161615
Dytide H
HE310127
Hydrochlorothiazide - triamterene mixt.
Hydrochlorothiazide and triamterene
Hydrochlorothiazide mixture with Triamterene
Hydrochlorothiazide-triamterene
HYDROCHLOROTHIAZIDE; TRIAMTERENE
LS-178541
Novotriamazide
SCHEMBL931483
Slimin
Triampur (combination)
Triampur compositum
Triamterene - hydrochlorothiazide mixt.
Triamterene / HCTZ
Triamterene hydrochlorothiazide
Triamterene mixture with hydrochlorothiazide
Triamterene/HCTZ
Triamterene/hydrochlorothiazide

US Patents and Regulatory Information for TRIAMTERENE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074970-001 Jan 6, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 073449-001 Sep 23, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074857-001 Sep 9, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Johnson and Johnson
Argus Health
Julphar
AstraZeneca
Deloitte
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.